Stability Studies of the Vaccine Adjuvant U-Omp19

Unlipidated outer membrane protein 19 (U-Omp19) is a novel mucosal adjuvant in preclinical development to be used in vaccine formulations. U-Omp19 holds two main properties, it is capable of inhibiting gastrointestinal and lysosomal peptidases, increasing the amount of co-administered antigen that r...

Descripción completa

Detalles Bibliográficos
Autores principales: Darriba, M. Laura, Cerutti, María L., Bruno, Laura, Cassataro, Juliana, Pasquevich, Karina A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815325/
https://www.ncbi.nlm.nih.gov/pubmed/33058898
http://dx.doi.org/10.1016/j.xphs.2020.10.011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7815325/
https://www.ncbi.nlm.nih.gov/pubmed/33058898
http://dx.doi.org/10.1016/j.xphs.2020.10.011

Ejemplares similares